High doses of glucosamine-HCI have detrimental effects on bovine articular cartilage explants cultured in vitro

M. De Mattei, A. Pellati, M. Pasello, F. De Terlizzi, L. Massari, D. Gemmati, A. Caruso

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: To investigate both the biochemical and the potential morphological changes in bovine cartilage explants following treatment with glucosamine HCl, and to evaluate the capability of glucosamine to counteract the degradation of cartilage induced by catabolic agents such as interleukin-1 β (IL-1β) and the bacterial lipopolysaccharide (LPS). Design: Bovine articular cartilage explants were treated with increasing doses of glucosamine HCl (0.25-25 mg/ml) in the absence or in the presence of IL-β or LPS. The release of matrix proteoglycans in the medium, as well as variations in nitric oxide and lactate production were evaluated by standard assays. Proteoglycan synthesis was determined by incorporation of Na2-35SO4. Ultrastructural analysis was performed by transmission electron microscopy. Results: Increasing doses of glucosamine (2.5, 6.5, 25 mg/ml) induced a dose-dependent decrease in proteoglycan synthesis and in lactate production after 24 h treatment. The biochemical changes induced by IL1-β or LPS appeared to be inhibited by 6.5 and 25 mg/ml glucosamine. At these concentrations a decrease in cell viability was observed, which reached over 90% at 25 mg/ml. Conclusions: This study shows that pharmacological doses of glucosamine induce a broad impairment in the metabolic activity of bovine chondrocytes, leading to cell death. The inhibition of the catabolic effects induced by IL1-β and LPS appears related to glucosamine toxicity. In other experimental models, the same or similar doses of glucosamine have previously been used, without showing any adverse effect. We conclude that, in studying the effects of glucosamine, particular attention should be addressed to the experimental model, the doses and the length of treatment.

Original languageEnglish
Pages (from-to)816-825
Number of pages10
JournalOsteoarthritis and Cartilage
Volume10
Issue number10
DOIs
Publication statusPublished - Oct 1 2002

Fingerprint

Glucosamine
Cartilage
Articular Cartilage
Human computer interaction
Lipopolysaccharides
Proteoglycans
Lactic Acid
Theoretical Models
In Vitro Techniques
Nitric oxide
Cell death
Chondrocytes
Transmission Electron Microscopy
Interleukin-1
Toxicity
Assays
Cell Survival
Nitric Oxide
Cell Death
Cells

Keywords

  • Articular cartilage
  • Bovine
  • Glucosamine
  • Osteoarthritis

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

High doses of glucosamine-HCI have detrimental effects on bovine articular cartilage explants cultured in vitro. / De Mattei, M.; Pellati, A.; Pasello, M.; De Terlizzi, F.; Massari, L.; Gemmati, D.; Caruso, A.

In: Osteoarthritis and Cartilage, Vol. 10, No. 10, 01.10.2002, p. 816-825.

Research output: Contribution to journalArticle

De Mattei, M. ; Pellati, A. ; Pasello, M. ; De Terlizzi, F. ; Massari, L. ; Gemmati, D. ; Caruso, A. / High doses of glucosamine-HCI have detrimental effects on bovine articular cartilage explants cultured in vitro. In: Osteoarthritis and Cartilage. 2002 ; Vol. 10, No. 10. pp. 816-825.
@article{3d5cfd54f78b4504a5773536ee72a285,
title = "High doses of glucosamine-HCI have detrimental effects on bovine articular cartilage explants cultured in vitro",
abstract = "Objective: To investigate both the biochemical and the potential morphological changes in bovine cartilage explants following treatment with glucosamine HCl, and to evaluate the capability of glucosamine to counteract the degradation of cartilage induced by catabolic agents such as interleukin-1 β (IL-1β) and the bacterial lipopolysaccharide (LPS). Design: Bovine articular cartilage explants were treated with increasing doses of glucosamine HCl (0.25-25 mg/ml) in the absence or in the presence of IL-β or LPS. The release of matrix proteoglycans in the medium, as well as variations in nitric oxide and lactate production were evaluated by standard assays. Proteoglycan synthesis was determined by incorporation of Na2-35SO4. Ultrastructural analysis was performed by transmission electron microscopy. Results: Increasing doses of glucosamine (2.5, 6.5, 25 mg/ml) induced a dose-dependent decrease in proteoglycan synthesis and in lactate production after 24 h treatment. The biochemical changes induced by IL1-β or LPS appeared to be inhibited by 6.5 and 25 mg/ml glucosamine. At these concentrations a decrease in cell viability was observed, which reached over 90{\%} at 25 mg/ml. Conclusions: This study shows that pharmacological doses of glucosamine induce a broad impairment in the metabolic activity of bovine chondrocytes, leading to cell death. The inhibition of the catabolic effects induced by IL1-β and LPS appears related to glucosamine toxicity. In other experimental models, the same or similar doses of glucosamine have previously been used, without showing any adverse effect. We conclude that, in studying the effects of glucosamine, particular attention should be addressed to the experimental model, the doses and the length of treatment.",
keywords = "Articular cartilage, Bovine, Glucosamine, Osteoarthritis",
author = "{De Mattei}, M. and A. Pellati and M. Pasello and {De Terlizzi}, F. and L. Massari and D. Gemmati and A. Caruso",
year = "2002",
month = "10",
day = "1",
doi = "10.1053/joca.2002.0834",
language = "English",
volume = "10",
pages = "816--825",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - High doses of glucosamine-HCI have detrimental effects on bovine articular cartilage explants cultured in vitro

AU - De Mattei, M.

AU - Pellati, A.

AU - Pasello, M.

AU - De Terlizzi, F.

AU - Massari, L.

AU - Gemmati, D.

AU - Caruso, A.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Objective: To investigate both the biochemical and the potential morphological changes in bovine cartilage explants following treatment with glucosamine HCl, and to evaluate the capability of glucosamine to counteract the degradation of cartilage induced by catabolic agents such as interleukin-1 β (IL-1β) and the bacterial lipopolysaccharide (LPS). Design: Bovine articular cartilage explants were treated with increasing doses of glucosamine HCl (0.25-25 mg/ml) in the absence or in the presence of IL-β or LPS. The release of matrix proteoglycans in the medium, as well as variations in nitric oxide and lactate production were evaluated by standard assays. Proteoglycan synthesis was determined by incorporation of Na2-35SO4. Ultrastructural analysis was performed by transmission electron microscopy. Results: Increasing doses of glucosamine (2.5, 6.5, 25 mg/ml) induced a dose-dependent decrease in proteoglycan synthesis and in lactate production after 24 h treatment. The biochemical changes induced by IL1-β or LPS appeared to be inhibited by 6.5 and 25 mg/ml glucosamine. At these concentrations a decrease in cell viability was observed, which reached over 90% at 25 mg/ml. Conclusions: This study shows that pharmacological doses of glucosamine induce a broad impairment in the metabolic activity of bovine chondrocytes, leading to cell death. The inhibition of the catabolic effects induced by IL1-β and LPS appears related to glucosamine toxicity. In other experimental models, the same or similar doses of glucosamine have previously been used, without showing any adverse effect. We conclude that, in studying the effects of glucosamine, particular attention should be addressed to the experimental model, the doses and the length of treatment.

AB - Objective: To investigate both the biochemical and the potential morphological changes in bovine cartilage explants following treatment with glucosamine HCl, and to evaluate the capability of glucosamine to counteract the degradation of cartilage induced by catabolic agents such as interleukin-1 β (IL-1β) and the bacterial lipopolysaccharide (LPS). Design: Bovine articular cartilage explants were treated with increasing doses of glucosamine HCl (0.25-25 mg/ml) in the absence or in the presence of IL-β or LPS. The release of matrix proteoglycans in the medium, as well as variations in nitric oxide and lactate production were evaluated by standard assays. Proteoglycan synthesis was determined by incorporation of Na2-35SO4. Ultrastructural analysis was performed by transmission electron microscopy. Results: Increasing doses of glucosamine (2.5, 6.5, 25 mg/ml) induced a dose-dependent decrease in proteoglycan synthesis and in lactate production after 24 h treatment. The biochemical changes induced by IL1-β or LPS appeared to be inhibited by 6.5 and 25 mg/ml glucosamine. At these concentrations a decrease in cell viability was observed, which reached over 90% at 25 mg/ml. Conclusions: This study shows that pharmacological doses of glucosamine induce a broad impairment in the metabolic activity of bovine chondrocytes, leading to cell death. The inhibition of the catabolic effects induced by IL1-β and LPS appears related to glucosamine toxicity. In other experimental models, the same or similar doses of glucosamine have previously been used, without showing any adverse effect. We conclude that, in studying the effects of glucosamine, particular attention should be addressed to the experimental model, the doses and the length of treatment.

KW - Articular cartilage

KW - Bovine

KW - Glucosamine

KW - Osteoarthritis

UR - http://www.scopus.com/inward/record.url?scp=0036793172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036793172&partnerID=8YFLogxK

U2 - 10.1053/joca.2002.0834

DO - 10.1053/joca.2002.0834

M3 - Article

C2 - 12359168

AN - SCOPUS:0036793172

VL - 10

SP - 816

EP - 825

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 10

ER -